Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,775 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,528)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02755337 | The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase(EVALUATE) | unknown | — | 70 | Dr. Soetomo General HospitalOTHER_GOV | 1 | Apr 28, 2016 | clinicaltrials |
| NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013(CBPC) | unknown | Phase 3 | 164 | University Hospital, AngersOTHER_GOV | 1 |
| Apr 25, 2016 |
| clinicaltrials |
| NCT02462356 | Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer(MVUVLC) | unknown | N/A | 70 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT02737735 | The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation | unknown | Phase 1 | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02738593 | Detection Cell Free DNA in Lung Cancer Patients | unknown | — | 124 | Sun Yat-sen UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02738684 | A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test | unknown | — | 100 | Southwest Hospital, ChinaOTHER | 0 | Apr 14, 2016 | clinicaltrials |
| NCT02738723 | SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC | unknown | Phase 2 | 50 | Third Military Medical UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02738983 | RT Plus EGFR-TKI for Wild-type NSCLC | unknown | Phase 2 | 22 | Hangzhou Cancer HospitalOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02736916 | HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer | unknown | N/A | 3 | General Hospital of Ningxia Medical UniversityOTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT02733107 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 25 | Third Military Medical UniversityOTHER | 1 | Apr 12, 2016 | clinicaltrials |
| NCT00690963 | Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating | unknown | Phase 1 / Phase 2 | 12 | AHS Cancer Control AlbertaOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT01977235 | Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer(TDICC) | unknown | Phase 2 | 110 | Third Military Medical UniversityOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT02031601 | Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer(TCL-1) | unknown | Phase 4 | 250 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT00122239 | A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers | unknown | — | 13 | AHS Cancer Control AlbertaOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT02618590 | A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure | unknown | — | 800 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT02708667 | An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients | unknown | — | 50 | Sun Yat-sen UniversityOTHER | 1 | Mar 15, 2016 | clinicaltrials |
| NCT02704767 | Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma | unknown | Phase 2 | 60 | First Affiliated Hospital of Kunming Medical UniversityOTHER | 0 | Mar 10, 2016 | clinicaltrials |
| NCT02691871 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR | unknown | Phase 1 | 20 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Feb 25, 2016 | clinicaltrials |
| NCT02037997 | Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC | unknown | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02688673 | DC Vaccine Combined With CIK Cells in Patients With SCLC | unknown | Phase 1 / Phase 2 | 30 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 0 | Feb 23, 2016 | clinicaltrials |
| NCT02686775 | The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients(PACO) | unknown | N/A | 306 | Danish Cancer SocietyOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT02270853 | SAS in Patients With Bronchial Carcinoma(SAS CA) | unknown | N/A | 100 | RWTH Aachen UniversityOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT01393080 | Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients(NSCLC) | unknown | N/A | 160 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02665390 | Percutaneous Cryoablation Peripheral Lung Cancer(PCPLC) | unknown | N/A | 30 | Shanghai Chest HospitalOTHER | 0 | Feb 12, 2016 | clinicaltrials |
| NCT01784107 | A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 45 | Gachon University Gil Medical CenterOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT02669719 | Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC | unknown | Phase 2 | 70 | Shanghai Chest HospitalOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT01801852 | Autologous Natural Killer T Cells Infusion for the Treatment of Cancer | unknown | N/A | 300 | Chinese PLA General HospitalOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02663492 | Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients | unknown | N/A | 300 | Tongji UniversityOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02661009 | Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method) | unknown | — | 1,000 | GenoSaberINDUSTRY | 0 | Jan 21, 2016 | clinicaltrials |
| NCT02650544 | Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression | unknown | Phase 2 | 236 | Sun Yat-sen UniversityOTHER | 1 | Jan 8, 2016 | clinicaltrials |
| NCT02644889 | EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment | unknown | — | 100 | GenoSaberINDUSTRY | 0 | Jan 7, 2016 | clinicaltrials |
| NCT02647164 | The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring | unknown | — | 360 | GenoSaberINDUSTRY | 0 | Jan 6, 2016 | clinicaltrials |
| NCT02648087 | Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer(NEOSAS) | unknown | N/A | 1,200 | University Hospital, AngersOTHER_GOV | 0 | Jan 6, 2016 | clinicaltrials |
| NCT02643407 | Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer | unknown | Phase 3 | 488 | Guangdong Association of Clinical TrialsOTHER | 1 | Dec 31, 2015 | clinicaltrials |
| NCT00973310 | Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer | unknown | Phase 2 | 50 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01255059 | GWAS Research of Lung Cancer in Tianjin | unknown | — | 500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01660399 | Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy | unknown | Phase 2 | 300 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02631460 | S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC | unknown | Phase 2 | 470 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT01494415 | Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer | unknown | Phase 2 | 21 | First People's Hospital of HangzhouOTHER | 1 | Dec 15, 2015 | clinicaltrials |
| NCT01891123 | Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy | unknown | N/A | 300 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT02445872 | Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy | unknown | Phase 2 | 80 | Zhejiang UniversityOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT02603627 | Prevalence of COPD in Our Lung Cancer Population, Compared to Controls | unknown | — | 200 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Nov 13, 2015 | clinicaltrials |
| NCT02273271 | Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo(EVIDENCE) | unknown | N/A | 31 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Oct 30, 2015 | clinicaltrials |
| NCT02584699 | Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC | unknown | Phase 2 | 40 | Luhua WangUNKNOWN | 1 | Oct 23, 2015 | clinicaltrials |
| NCT02395939 | Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL(CT-CROP) | unknown | Phase 3 | 158 | Middlemore Hospital, New ZealandOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT02555592 | Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level | unknown | — | 25 | Pusan National University HospitalOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT02549261 | Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer | unknown | N/A | 150 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT01646450 | First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients | unknown | Phase 4 | 35 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 9, 2015 | clinicaltrials |
| NCT01707329 | Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 9, 2015 | clinicaltrials |
| NCT02540824 | Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Sep 4, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Apr 28, 2016source: clinicaltrials